Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Mostra altre versioni (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
di: Psarros, C, et al.
Pubblicazione: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
di: Psarros, C, et al.
Pubblicazione: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
di: Jingyun Cheng, et al.
Pubblicazione: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
di: Shuihua Zhang, et al.
Pubblicazione: (2020-01-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
di: Antonopoulos, A, et al.
Pubblicazione: (2010)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
di: Yongfang Lin, et al.
Pubblicazione: (2024-06-01)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
di: Antoniades, C, et al.
Pubblicazione: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
di: Ying Tao, et al.
Pubblicazione: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
di: Qinggong Han, et al.
Pubblicazione: (2022-10-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
di: Antonopoulos, A, et al.
Pubblicazione: (2009)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
di: Ping Ping Hu, et al.
Pubblicazione: (2022-09-01)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
di: Xue Li, et al.
Pubblicazione: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
di: Antoniades, C, et al.
Pubblicazione: (2011)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
di: D. Gao, et al.
Pubblicazione: (2020-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
di: Yee Shan Wong, et al.
Pubblicazione: (2019-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
di: Yee Shan Wong, et al.

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
di: Bakogiannis, C, et al.
Pubblicazione: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
di: Zhiyue Wang, et al.
Pubblicazione: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
di: Ruolin Wu, et al.
Pubblicazione: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
di: Margaritis, M
Pubblicazione: (2016)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
di: Siasos, G, et al.
Pubblicazione: (2007)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
di: Margaritis, M, et al.
Pubblicazione: (2013)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
di: Margaritis, M, et al.
Pubblicazione: (2013)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
di: Akoumianakis, I, et al.
Pubblicazione: (2020)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
di: Yuanyuan Peng, et al.
Pubblicazione: (2025-06-01)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
di: Akoumianakis, I, et al.
Pubblicazione: (2018)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
di: Margaritis, M, et al.
Pubblicazione: (2012)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
di: Sijin Chen, et al.
Pubblicazione: (2024-10-01)

Biomarkers of premature atherosclerosis.
di: Kampoli, A, et al.
Pubblicazione: (2009)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
di: Luona Yang, et al.
Pubblicazione: (2023-05-01)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
di: Antoniades, C, et al.
Pubblicazione: (2011)

Challenges to Safe Nanomedicine Treatment
di: Chunhua Yang, et al.
Pubblicazione: (2023-03-01)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
di: Bumb, A, et al.
Pubblicazione: (2009)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
di: Polkinghorne, M, et al.
Pubblicazione: (2022)

Homocysteine lowering: any use in atherosclerosis?
di: Antoniades, C, et al.
Pubblicazione: (2007)

Perivascular adipose tissue and coronary atherosclerosis
di: Mancio, J, et al.
Pubblicazione: (2018)

State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?
di: Antoniades, C, et al.
Pubblicazione: (2019)

Nanomedicine Explored at Molecular Imaging Summit
di: Julie L. Sutcliffe PhD
Pubblicazione: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
di: Evelien Hesemans, et al.
Pubblicazione: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
di: Pan He, et al.
Pubblicazione: (2023-08-01)